Research progress of anti-glioma chemotherapeutic drugs (Review)
| Autor: | Yi-Shu, Zhou, Wei, Wang, Na, Chen, Li-Cui, Wang, Jin-Bai, Huang |
|---|---|
| Rok vydání: | 2022 |
| Předmět: | |
| Zdroj: | Oncology Reports. 47 |
| ISSN: | 1791-2431 1021-335X |
| DOI: | 10.3892/or.2022.8312 |
| Popis: | Glioma is the most common primary intracranial malignancy in the central nervous system. At present, the most important treatment option is surgical resection of the tumor combined with radiotherapy and chemotherapy. The principle of operation is to remove the tumor to the maximal extent on the basis of preserving brain function. However, prominent invasive and infiltrative proliferation of glioma tumor cells into the surrounding normal tissues frequently reduces the efficacy of treatment. This in turn worsens the prognosis, because the tumor cannot be completely removed, which can readily relapse. Chemotherapeutic agents when applied individually have demonstrated limited efficacy for the treatment of glioma. However, multiple different chemotherapeutic agents can be used in combination with other treatment modalities to improve the efficacy while circumventing systemic toxicity and drug resistance. Therefore, it is pivotal to unravel the inhibitory mechanism mediated by the different chemotherapeutic drugs on glioma cells in preclinical studies. The aim of the present review is to provide a summary for understanding the effects of different chemotherapeutic drugs in glioma, in addition to providing a reference for the preclinical research into novel chemotherapeutic agents for future clinical application. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|